On June 27th, the Management Bureau of Hainan Boao Lecheng International Medical Tourism Pilot Zone (hereinafter referred to as "Lecheng Management Bureau") signed a cooperation agreement with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as "Fosun Pharmaceutical").
The two sides will cooperate in the transformation and application of innovative medical devices, diagnostic technologies, and products based on Lecheng real world data, as well as pilot trials, the introduction of urgently needed overseas medical devices in clinical practice, regional cooperation among medical institutions, and the strengthening of disciplinary talent cultivation. This will further promote the introduction and implementation of global innovative treatment plans, facilitate the accessibility of high-quality medical and health services, and meet the clinical needs of more Chinese patients.
Jia Ning, Director of Lecheng Administration Bureau, Li Yunda, Deputy Director of Hainan Provincial Drug Administration Bureau, Fu Zhu, Deputy Director of Lecheng Administration Bureau, Wang Yanfang, Director of Health Industry and Foreign Cooperation Bureau of Hainan Provincial Health Commission, Chen Linmin, Deputy Director of Social Department of Hainan Provincial Development and Reform Commission, Chen Qiyu, Executive Director and Co CEO of Fosun International, and Wang Kexin, Vice President of Fosun International and Co Chairman of Fosun Pharmaceutical, attended the signing ceremony.
Fu Zhu represents the Lecheng Management Bureau, and Wang Kexin represents Fosun Pharmaceutical to sign the contract. Jia Ning, Li Yunda, Wang Yanfang, Chen Linmin, and Chen Qiyu witnessed the signing of the contract.
Lecheng, as the only "medical special zone" in the construction of Hainan Free Trade Port, has unique innovative policies and geographical advantages. Fosun Pharmaceutical takes innovative research and development as the core driving factor, and has mature industry chain capabilities in research and development, clinical trials, production, and sales, as well as successful experience in introducing and landing multiple globally leading products. The signing of this cooperation agreement means that both parties will jointly explore the reform and innovation of pharmaceutical policies, take the lead and try, further extend the industrial chain of both parties, enrich industrial formats, and promote the high standard and high-quality development of Lecheng International Medical Tourism and high-end medical services in the context of the construction of a free trade port with Chinese characteristics.
Jia Ning, Director of the Management Bureau of Lecheng Pilot Zone, stated that this signing and cooperation is another important measure for Lecheng to deeply implement the spirit of Secretary Shen Xiaoming's speech during his research in Lecheng Pilot Zone, introduce industry-leading market entities, and accelerate the gathering of high-quality industrial resources. The signing of this cooperation agreement will fully leverage the advantages of Lecheng Pilot Zone policy, natural resources, industrial foundation, etc., gather the talents, technology, research and development advantages of Fosun Pharmaceutical Company, and promote mutual complementarity, deepening cooperation, and common development between the two sides. In the future, both parties will rely on their respective resource advantages to accelerate the transformation and application of scientific research achievements in innovative drugs, medical devices, diagnostic technologies, and products, and promote the aggregation of high-quality medical resources and medical technology innovation resources. Lecheng Management Bureau will fully provide high-quality and efficient services, promote the comprehensive implementation of cooperation agreements, and assist in the high-quality development of the medical and health industry and biopharmaceutical industry in Hainan Free Trade Port.
Chen Qiyu, Executive Director and Co CEO of Fosun International, stated that Lecheng has special geographical and policy advantages, combined with Lecheng's innovative policies and expert resources for real world research, giving Lecheng greater advantages in industry introduction. As a pioneer in the international expansion of the big health field, Fosun Pharmaceuticals' collaboration with Lecheng this time is also based on Lecheng's active implementation of supporting policies in various aspects of innovative medicine and equipment, as well as the development of industrial clusters. We hope that through cooperation between both parties, Fosun Pharma can integrate into Lecheng, the "hot land" of medical tourism reform and opening up, integrate into the development of Hainan, share the "Lecheng Plan" and "Hainan Wisdom", contribute to the construction of Lecheng as a world-class international medical tourism destination and medical technology innovation platform, meet the needs of more patients, and assist in the high-quality and high standard construction of Hainan Free Trade Port.
It is reported that Fosun Pharmaceutical has multiple medical institutions in multiple key regions across the country, such as the Greater Bay Area and the Yangtze River Delta, with high-quality subject matter expert resources and rich operational experience. The Lecheng Pilot Zone has a brand effect, a medical and health industry cluster, a good ecological environment, and abundant tourism resources in the surrounding areas. Through this cooperation, both parties will jointly promote the sharing of high-quality medical resources and provide more patients with high-quality medical services such as physical examinations and health management, traditional Chinese medicine health care, etc.
In the future, both sides will continue to explore broad opportunities for cooperation in fields such as medicine, education, research, and industry, and jointly promote the innovative development of China's major health industry.
Xie Dazhi, the lifelong dean of Foshan Fosun Chancheng Hospital, Hu Hang, Senior Vice President of Fosun Pharmaceuticals, President of Fosun Health, and Dean of Foshan Fosun Chancheng Hospital, Bao Qingui, Senior Vice President of Fosun Pharmaceuticals and Chairman of Medical Diagnosis Business Unit, Liu Zhongsen, Assistant President of Fosun International and Chief Executive Representative of Hainan, and others attended the signing event.